Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00274
|
|||||
Drug Name |
Docosahexaenoic acid
|
|||||
Synonyms |
(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid; (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid; 6217-54-5; AquaGrow Advantage; CCRIS 7670; CHEMBL367149; Cervonic acid; Doconexent; Doconexento; Doconexentum; Docosahexaenoate; Docosahexaenoic acid; Docosahexaenoic acid (all-Z); Doxonexent; Eicosapentaenoic acid/docosa-hexaenoic acid; Martek DHA HM; Ropufa 60; UNII-ZAD9OKH9JC; ZAD9OKH9JC; all-Z-Docosahexaenoic acid; all-cis-4,7,10,13,16,19-Docosahexaenoic acid; all-cis-DHA; all-cis-docosa-4,7,10,13,16,19-hexaenoic acid; cis-4,7,10,13,16,19-Docosahexaenoic acid
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Alzheimer disease [ICD11:8A20] | Phase 3 | [1] | |||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C22H32O2
|
|||||
Canonical SMILES |
CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)O
|
|||||
InChI |
InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-
|
|||||
InChIKey |
MBMBGCFOFBJSGT-KUBAVDMBSA-N
|
|||||
CAS Number |
CAS 6217-54-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 328.5 | Topological Polar Surface Area | 37.3 | ||
Heavy Atom Count | 24 | Rotatable Bond Count | 14 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
6.2
|
|||||
PubChem CID | ||||||
PubChem SID |
10299728
,103445456
,104046523
,104086818
,104179148
,104634620
,118048648
,126524415
,126621028
,126655302
,134350834
,135028589
,135651477
,137003172
,142339426
,144205545
,14924254
,152101578
,162180738
,162227670
,163659264
,24893696
,26754926
,26754927
,26754928
,36888254
,46391883
,47515089
,47515090
,47885165
,48184752
,50110834
,50110835
,57404690
,75281905
,7850049
,81063745
,8144392
,839059
,841847
,85787686
,8664
,87568664
,91695933
,92165132
,92298371
,92309714
,92719165
,99300628
,99302146
|
|||||
ChEBI ID |
ChEBI:28125
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | MFSD2A | Transporter Info | Major facilitator superfamily domain-containing protein 2A | Substrate | [2] | |
References | ||||||
1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1051). | |||||
2 | Mfsd2a Is a Transporter for the Essential -3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development. J Biol Chem. 2016 May 13;291(20):10501-14. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.